Among analytes that exhibited a significant fold increase in MPN patients versus controls, Dkk‐1 showed the highest potential for discrimination between MPN subtypes and was selected for further study (P = .0031, one‐way ANOVA, Figure 1C). The gene discussed is DKK1; the disease is myeloproliferative neoplasm.